Tinavi Medical Technologies Co Ltd (688277) — Cash Flow-to-Debt Ratio

Latest as of September 2025: 0.05x

Tinavi Medical Technologies Co Ltd (688277) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥24.50 Million could theoretically repay 0% of its total liabilities (CN¥484.88 Million) in one year. See 688277 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

CF-to-Debt Ratio

0.05x
Operating CF / Total Liabilities

Operating Cash Flow

CN¥24.50 Million
CNY

Total Liabilities

CN¥484.88 Million
CNY

Data as of

Sep 2025
Most recent filing

Tinavi Medical Technologies Co Ltd Cash Flow-to-Debt Ratio (2013–2024)

Historical debt coverage capacity for Tinavi Medical Technologies Co Ltd across 12 annual periods. Also explore 688277 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Annual Cash Flow-to-Debt Ratio for Tinavi Medical Technologies Co Ltd (2013–2024)

Year-by-year debt coverage analysis for Tinavi Medical Technologies Co Ltd. For market capitalisation and broader financial context, see how much is Tinavi Medical Technologies Co Ltd worth.

Year CF-to-Debt Ratio Operating CF (CNY) Total Liabilities YoY Change
2024 -0.24x CN¥-98.65 Million CN¥411.58 Million ▲ +46.3%
2023 -0.45x CN¥-170.50 Million CN¥381.95 Million ▼ -47.6%
2022 -0.30x CN¥-87.51 Million CN¥289.39 Million ▲ +17.8%
2021 -0.37x CN¥-77.76 Million CN¥211.48 Million ▲ +40.8%
2020 -0.62x CN¥-57.58 Million CN¥92.73 Million ▼ -454.6%
2019 0.18x CN¥20.53 Million CN¥117.26 Million ▲ +35.9%
2018 0.13x CN¥13.15 Million CN¥102.05 Million ▲ +919.9%
2017 0.01x CN¥5.73 Million CN¥453.26 Million ▲ +101.9%
2016 -0.67x CN¥-32.70 Million CN¥49.16 Million ▼ -112.7%
2015 5.24x CN¥41.82 Million CN¥7.98 Million ▲ +320.6%
2014 -2.38x CN¥-33.84 Million CN¥14.25 Million ▼ -726.6%
2013 -0.29x CN¥-3.38 Million CN¥11.76 Million
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.